CompletedNot Applicable

Mechanical Complications After Central Venous Catheterisation

Sweden12,600 participantsStarted 2019-03-01

Plain-language summary

Central venous catheters are common in modern health care and are being increasingly used in both intensive care units and general wards. The primary aim of this study is to determine the incidence of mechanical complications within 24 hours after central venous catheterisation. The secondary aim is to identify risk factors associated with mechanical complications within 24 hours after catheterisation.

Who can participate

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * All patients receiving a central venous catheter will be observed Exclusion Criteria: * Patients that dies within 24 hours after insertion of a central venous catheter

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Number of cases with bleeding grade 3-4

Timeframe: Up to 24 hours after insertion of the central venous catheter

Number of cases with bleeding grad 2

Timeframe: Up to 24 hours after insertion of the central venous catheter

Number of cases with pneumothorax at post-procedural x-ray of the thorax

Timeframe: Up to 24 hours after insertion of the central venous catheter

Number of cases with arterial puncture evident at the insertion procedure by the inserting physician

Timeframe: During the procedure of inserting the central venous catheter

Number of cases with arterially positioned catheter at post-procedural x-ray

Timeframe: Up to 24 hours after insertion of the central venous catheter

Number of cases with persistent nerve injury classified as sensory loss, paraesthesia or loss of motor neuron function recognized by the responsible physician or nurse

Timeframe: Persistent more than 72 hours after insertion of the central venous catheter

Trial details

NCT IDNCT03782324

SponsorRegion Skane

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2020-12-31

View on ClinicalTrials.gov More Mechanical Complications of Central Venous Catheter trials